Free Trial

Blueprint Medicines (BPMC) SEC Filings & 10K Form

$116.81
+1.84 (+1.60%)
(As of 07/22/2024 ET)

Recent Blueprint Medicines SEC Filings

DateFilerForm TypeView
07/08/2024
6:07 PM
Blueprint Medicines (Issuer)
Rossi Christina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2024
6:08 PM
Blueprint Medicines (Issuer)
Carter Percy H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
4:54 PM
Blueprint Medicines (Subject)
Durso-Bumpus Debra (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/21/2024
3:36 PM
Blueprint Medicines (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/14/2024
4:32 PM
Blueprint Medicines (Issuer)
Dable Habib J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:32 PM
Blueprint Medicines (Issuer)
Borisy Alexis (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:34 PM
Blueprint Medicines (Issuer)
Goldberg Mark Alan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:34 PM
Blueprint Medicines (Issuer)
Lydon Nicholas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:35 PM
Blueprint Medicines (Issuer)
Seely Lynn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:36 PM
Blueprint Medicines (Issuer)
Tsai John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:37 PM
Blueprint Medicines (Issuer)
COATS LONNEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:38 PM
Beckman Daniella (Reporting)
Blueprint Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:41 PM
Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
4:11 PM
Blueprint Medicines (Subject)
Carter Percy H. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/04/2024
3:40 PM
Blueprint Medicines (Subject)
Hewes L. Becker (Reporting)
Hewes L. Becker (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/31/2024
3:38 PM
Blueprint Medicines (Subject)
Hewes L. Becker (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/24/2024
7:00 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2024
4:19 PM
Blueprint Medicines (Issuer)
Hurley Ariel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2024
4:26 PM
Blueprint Medicines (Issuer)
Landsittel Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
3:43 PM
Blueprint Medicines (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/02/2024
6:09 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2024
6:09 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2024
4:24 PM
Blueprint Medicines (Filer)
Form DEF 14A
04/25/2024
4:25 PM
Blueprint Medicines (Filer)
Form ARS
04/25/2024
7:30 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2024
11:58 AM
Blueprint Medicines (Subject)
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
Form SC 13G/A
03/28/2024
4:57 PM
Blueprint Medicines (Subject)
Landsittel Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/26/2024
8:11 PM
Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2024
4:50 PM
Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
4:22 PM
Blueprint Medicines (Subject)
Landsittel Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/15/2024
3:46 PM
Blueprint Medicines (Subject)
Hurley Ariel (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/15/2024
3:47 PM
Blueprint Medicines (Issuer)
Lee Philina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2024
3:17 PM
Blueprint Medicines (Subject)
Lee Philina (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/11/2024
5:24 PM
Blueprint Medicines (Issuer)
Murray Christopher K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
5:26 PM
Blueprint Medicines (Issuer)
Lee Philina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
5:27 PM
Blueprint Medicines (Issuer)
Haviland Kate (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
5:28 PM
Blueprint Medicines (Issuer)
Durso-Bumpus Debra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
5:29 PM
Blueprint Medicines (Issuer)
Hewes L. Becker (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
5:15 PM
Blueprint Medicines (Issuer)
Hurley Ariel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
5:18 PM
Blueprint Medicines (Issuer)
McCain Tracey L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
5:19 PM
Blueprint Medicines (Issuer)
Carter Percy H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This AI made her leave her job (Ad)

This AI trading tool is probably unlike anything you've ever seen before… It scans the entire market and finds hot stocks that you probably have never even heard of… …it recommends the best potential strategy to use on the names it finds (with historical data to prove it)

Click Here To Read More About This Game Changing AI Tool
03/11/2024
5:20 PM
Blueprint Medicines (Issuer)
Namouni Fouad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
5:21 PM
Blueprint Medicines (Issuer)
Rossi Christina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
5:23 PM
Blueprint Medicines (Issuer)
Landsittel Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
3:22 PM
Blueprint Medicines (Issuer)
Lee Philina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
3:15 PM
Blueprint Medicines (Issuer)
Hurley Ariel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
3:16 PM
Blueprint Medicines (Issuer)
Carter Percy H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
3:17 PM
Blueprint Medicines (Issuer)
Landsittel Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
3:18 PM
Blueprint Medicines (Issuer)
Haviland Kate (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
3:19 PM
Blueprint Medicines (Issuer)
Hewes L. Becker (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
3:20 PM
Blueprint Medicines (Issuer)
Rossi Christina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
3:20 PM
Blueprint Medicines (Issuer)
Durso-Bumpus Debra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
3:21 PM
Blueprint Medicines (Issuer)
Namouni Fouad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
9:41 AM
Blueprint Medicines (Issuer)
Murray Christopher K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
5:19 PM
Blueprint Medicines (Subject)
Murray Christopher K. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/01/2024
2:06 PM
Blueprint Medicines (Issuer)
Murray Christopher K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
3:03 PM
Blueprint Medicines (Subject)
Murray Christopher K. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/22/2024
7:20 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/16/2024
3:40 PM
Blueprint Medicines (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/15/2024
4:26 PM
Blueprint Medicines (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/15/2024
6:05 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
5:54 PM
Blueprint Medicines (Issuer)
Lee Philina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
7:35 AM
Blueprint Medicines (Subject)
FMR LLC (Filed by)
Form SC 13G/A
01/29/2024
5:13 PM
Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2024
8:46 AM
BlackRock Inc. (Filed by)
Blueprint Medicines (Subject)
Form SC 13G/A
01/10/2024
9:16 AM
Blueprint Medicines (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
01/08/2024
7:03 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/26/2023
3:24 PM
Blueprint Medicines (Issuer)
Hurley Ariel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2023
2:56 PM
Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2023
5:09 PM
Blueprint Medicines (Subject)
Murray Christopher K. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/06/2023
7:45 PM
Blueprint Medicines (Issuer)
Murray Christopher K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/24/2023
12:17 PM
Albers Jeffrey W. (Reporting)
Blueprint Medicines (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/13/2023
8:02 AM
Blueprint Medicines (Subject)
FMR LLC (Filed by)
Form SC 13G/A
10/30/2023
1:01 PM
Blueprint Medicines (Issuer)
Murray Christopher K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/26/2023
6:00 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/05/2023
9:47 AM
Blueprint Medicines (Issuer)
Namouni Fouad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/29/2023
1:36 PM
Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/28/2023
5:23 PM
Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/25/2023
7:15 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/24/2023
3:21 PM
Albers Jeffrey W. (Reporting)
Blueprint Medicines (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/02/2023
3:02 PM
Blueprint Medicines (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/02/2023
6:00 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:BPMC) was last updated on 7/23/2024 by MarketBeat.com Staff

From Our Partners